1,1,2,2-Tetrakis(4-(1H-imidazol-1-yl)phenyl)ethene, 97%, 5g

2-(2-Chlorophenoxy)acetamide oxime, 97.0%, 1g

Dilauryldimethylammonium Bromide>98.0%(T)500g

3-(Cyclopropylcarbamoyl)-2-fluorophenylboronic acid, 97%, 5g

Ethyl 4-oxo-7-(trifluoromethyl)-1,4-dihydroquinoline-3-carboxylate, 95.0%, 10g

2,5-Dibromo-3,4-dimethyl-thiophene, 95%, 250mg

tert-Butyl N-[(1S,3S)-3-hydroxycyclopentyl]-n-methylcarbamate, 98%, 1g

Glass vials with rolled rim, 20 ml, Height, 70 mm, 200 Piece(s)

5-bromo-3-iodo-4-methylpyridin-2-ol, 95.0%, 1g

SECOISOLARICIRESINOL DIGLUCOSIDE, 95%, 100mg

N-(6-Bromo-1,3-dimethyl-2-oxo-2,3-dihydro-1H-benzo[d]imidazol-5-yl)-2,2,2-trifluoroacetamide, 98%, 5g

beta-D-gentiobiose, min. 98%, for biochemistry, 250 mg, glass packaging

2-Methyl-4-(2-thienyl)-1,3-thiazole, 95%, 1g